Kedrion Biopharma Expands Immunoglobulin Therapies Portfolio
Jan 19, 2016 |
CORPORATE
Gains Commercial Rights in the U.S. to BIVIGAM®, a Recently Approved IGIV Brand
KEDPlasma welcomes donors to its new Augsburg collection center
Jul 19, 2015 |
CORPORATE
Plasma collected in Germany is essential to Kedrion Biopharma’s European plasma-derived therapies
Tuscany Italy adopts revolutionary PID testing
Jul 12, 2015 |
EVENTS
Kedrion S.p.A. at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies
Humanitarian programme augments access to clotting factors in developing countries
Jun 28, 2015 |
CORPORATE
Kedrion helps the WISH project come true: Italian CNS[NM1] and the World Federation of Hemophilia sign agreement in London
Kedrion Continues Global Expansion with Dedication Ceremony at US Facility
May 15, 2015 |
EVENTS
Biopharma Company Celebrates with Local Guests and Dignitaries in Melville, New York
Kedrion employees in the US volunteer to help others
Feb 18, 2015 |
CORPORATE
Leaving every place we visit a little better than when we arrived: this is Kedrion Cares
Licenses for RhoGAM® and MICRhoGAM® transferred to Kedrion
Feb 17, 2015 |
CORPORATE
This is a milestone in consolidating our portfolio of plasma-derived products